Possibility of multiple market sensitive announcements from now till AGM
TGA approval for using BV gel in Australia
Signed agreements with partners to distribute BV gel in EU
Japanese approval for condom distribution and marketing in retail outlets (been almost 2 years since goal posts were changed by regulators)
Completed enrollment 0f Phase 1 clinical trials for Dep Docetaxel
Astrazeneca booting the preclinical trial to Phase 1 trial with Starpharma's drug delivery technology and cash payments
On another note - due to FDA changing goal posts and accepting the results from previous BV Phase 3 trials, and SPA (special protocal assessment) with Starpharma on current BV Phase 3 trials, there is 100 % certainty of successful current trial
How long before penny drops for those that are looking for a bargain
- Forums
- ASX - By Stock
- Starpharma, Sanofi Avantis's Jevtana®, Roche’s Kadcyla® and a 3 billion dollar business
Possibility of multiple market sensitive announcements from now...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5684 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 56840 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5684 | 0.100 |
1 | 300000 | 0.098 |
3 | 536417 | 0.095 |
2 | 10000 | 0.094 |
2 | 34393 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 56840 | 1 |
0.100 | 148705 | 4 |
0.105 | 96531 | 4 |
0.110 | 39609 | 6 |
0.115 | 138531 | 6 |
Last trade - 09.50am 24/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online